日本-话题@MedSci

#日本#

594篇内容 | 8355人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294495, encodeId=ee051294495bd, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, objectType=article, longId=179454, objectId=c7ad1e945427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ad1e945427, replyNumber=0, likeNumber=12, createdTime=2019-09-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ad1e945427, moduleTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ad1e945427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294494, encodeId=e358129449436, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本肿瘤防治经验和策略对我国的启示, objectType=article, longId=178533, objectId=92ef1e8533e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ef1e8533e9, replyNumber=0, likeNumber=67, createdTime=2019-09-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ef1e8533e9, moduleTitle=日本肿瘤防治经验和策略对我国的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ef1e8533e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294493, encodeId=04541294493b6, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本发布《2019年医药代表白皮书》, objectType=article, longId=178498, objectId=5a471e849894, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a471e849894, replyNumber=0, likeNumber=62, createdTime=2019-09-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a471e849894, moduleTitle=日本发布《2019年医药代表白皮书》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a471e849894)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294492, encodeId=c657129449256, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本宣布攻克白血病？真的假的？, objectType=article, longId=178353, objectId=5acb1e8353fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acb1e8353fa, replyNumber=0, likeNumber=18, createdTime=2019-08-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acb1e8353fa, moduleTitle=日本宣布攻克白血病？真的假的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acb1e8353fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294491, encodeId=bf1e1294491ef, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=葛兰素史克正在日本寻求daprodustat治疗肾性贫血的批准, objectType=article, longId=178103, objectId=a6711e8103b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6711e8103b1, replyNumber=0, likeNumber=75, createdTime=2019-08-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6711e8103b1, moduleTitle=葛兰素史克正在日本寻求daprodustat治疗肾性贫血的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6711e8103b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294490, encodeId=e6c012944901c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本一女性疑感染埃博拉出血热，安倍下令加强防疫, objectType=article, longId=176905, objectId=dad01e690587, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dad01e690587, replyNumber=0, likeNumber=70, createdTime=2019-08-06, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dad01e690587, moduleTitle=日本一女性疑感染埃博拉出血热，安倍下令加强防疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dad01e690587)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294489, encodeId=ed1e129448992, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=一位日本医药代表的一天, objectType=article, longId=176737, objectId=aff61e673765, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aff61e673765, replyNumber=0, likeNumber=61, createdTime=2019-08-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aff61e673765, moduleTitle=一位日本医药代表的一天, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aff61e673765)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294488, encodeId=cd0a12944881e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本游客游长城突发病晕倒，南京医生跪地抢救网上“爆红”, objectType=article, longId=176683, objectId=17371e668366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17371e668366, replyNumber=0, likeNumber=54, createdTime=2019-08-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17371e668366, moduleTitle=日本游客游长城突发病晕倒，南京医生跪地抢救网上“爆红”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17371e668366)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294487, encodeId=37ee129448e00, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Neurology：日本POEMS综合征的患病率、临床特征和预后, objectType=article, longId=176667, objectId=93221e666742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93221e666742, replyNumber=0, likeNumber=103, createdTime=2019-08-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93221e666742, moduleTitle=Neurology：日本POEMS综合征的患病率、临床特征和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93221e666742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294486, encodeId=677612944864b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=JAMA Neurol：日本研究称，血压降至<130/80 mmHg，可使卒中复发风险降低22%, objectType=article, longId=176642, objectId=a8cc1e6642f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8cc1e6642f1, replyNumber=0, likeNumber=59, createdTime=2019-08-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8cc1e6642f1, moduleTitle=JAMA Neurol：日本研究称，血压降至<130/80 mmHg，可使卒中复发风险降低22%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8cc1e6642f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294485, encodeId=3d751294485f1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本批准在动物体内培育人类脏器的研究项目, objectType=article, longId=176225, objectId=3b701e622500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b701e622500, replyNumber=0, likeNumber=97, createdTime=2019-07-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b701e622500, moduleTitle=日本批准在动物体内培育人类脏器的研究项目, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b701e622500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294484, encodeId=7b3612944842b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=从日本、新加坡经验看如何有效推进健康行动计划, objectType=article, longId=176078, objectId=e2831e6078c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2831e6078c6, replyNumber=0, likeNumber=65, createdTime=2019-07-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2831e6078c6, moduleTitle=从日本、新加坡经验看如何有效推进健康行动计划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2831e6078c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294483, encodeId=94a4129448351, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=AMR中心和日本Shionogi合作开发COT-143单抗，治疗铜绿假单胞菌感染, objectType=article, longId=176038, objectId=b5c41e6038a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5c41e6038a4, replyNumber=0, likeNumber=82, createdTime=2019-07-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5c41e6038a4, moduleTitle=AMR中心和日本Shionogi合作开发COT-143单抗，治疗铜绿假单胞菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5c41e6038a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294482, encodeId=0b8d12944822c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物, objectType=article, longId=175676, objectId=72801e567606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72801e567606, replyNumber=0, likeNumber=68, createdTime=2019-07-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72801e567606, moduleTitle=罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72801e567606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294481, encodeId=b823129448169, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=什么操作？日本将引入埃博拉等5种致命病毒, objectType=article, longId=174910, objectId=5c401e491048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c401e491048, replyNumber=0, likeNumber=69, createdTime=2019-07-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c401e491048, moduleTitle=什么操作？日本将引入埃博拉等5种致命病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c401e491048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294480, encodeId=60da1294480ab, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=早期诊断帕金森症有望？日本研发出血液检测法, objectType=article, longId=174761, objectId=b2011e4761c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2011e4761c7, replyNumber=0, likeNumber=104, createdTime=2019-07-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2011e4761c7, moduleTitle=早期诊断帕金森症有望？日本研发出血液检测法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2011e4761c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294479, encodeId=019e12944e90c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=为何日本中风患者过半康复而中国80%术后不能自理, objectType=article, longId=170082, objectId=e23f1e0082f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e23f1e0082f2, replyNumber=0, likeNumber=57, createdTime=2019-06-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e23f1e0082f2, moduleTitle=为何日本中风患者过半康复而中国80%术后不能自理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e23f1e0082f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294478, encodeId=77ee12944e89c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤, objectType=article, longId=168843, objectId=cbc71688433a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbc71688433a, replyNumber=0, likeNumber=70, createdTime=2019-06-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbc71688433a, moduleTitle=泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbc71688433a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294477, encodeId=61a112944e7c4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本发现一种抗乙肝病毒化合物, objectType=article, longId=168827, objectId=29be16882e75, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29be16882e75, replyNumber=0, likeNumber=83, createdTime=2019-06-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29be16882e75, moduleTitle=日本发现一种抗乙肝病毒化合物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29be16882e75)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294476, encodeId=afe812944e6e4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=全球首批！第一三共白血病疗法获批日本上市, objectType=article, longId=168773, objectId=de24168e736c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de24168e736c, replyNumber=0, likeNumber=61, createdTime=2019-06-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de24168e736c, moduleTitle=全球首批！第一三共白血病疗法获批日本上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de24168e736c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍

2019-09-16

chentianping (审核中...)

前往app查看评论内容

#日本#

日本肿瘤防治经验和策略对我国的启示

2019-09-03

chentianping (审核中...)

前往app查看评论内容

#日本#

日本发布《2019年医药代表白皮书》

2019-09-02

chentianping (审核中...)

前往app查看评论内容

#日本#

日本宣布攻克白血病？真的假的？

2019-08-30

chentianping (审核中...)

前往app查看评论内容

#日本#

葛兰素史克正在日本寻求daprodustat治疗肾性贫血的批准

2019-08-23

chentianping (审核中...)

前往app查看评论内容

#日本#

日本一女性疑感染埃博拉出血热，安倍下令加强防疫

2019-08-06

chentianping (审核中...)

前往app查看评论内容

#日本#

一位日本医药代表的一天

2019-08-04

chentianping (审核中...)

前往app查看评论内容

#日本#

日本游客游长城突发病晕倒，南京医生跪地抢救网上“爆红”

2019-08-04

chentianping (审核中...)

前往app查看评论内容

#日本#

Neurology：日本POEMS综合征的患病率、临床特征和预后

2019-08-03

chentianping (审核中...)

前往app查看评论内容

#日本#

JAMA Neurol：日本研究称，血压降至<130/80 mmHg，可使卒中复发风险降低22%

2019-08-03

chentianping (审核中...)

前往app查看评论内容

#日本#

日本批准在动物体内培育人类脏器的研究项目

2019-07-28

chentianping (审核中...)

前往app查看评论内容

#日本#

从日本、新加坡经验看如何有效推进健康行动计划

2019-07-25

chentianping (审核中...)

前往app查看评论内容

#日本#

AMR中心和日本Shionogi合作开发COT-143单抗，治疗铜绿假单胞菌感染

2019-07-25

chentianping (审核中...)

前往app查看评论内容

#日本#

罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物

2019-07-19

chentianping (审核中...)

前往app查看评论内容

#日本#

什么操作？日本将引入埃博拉等5种致命病毒

2019-07-07

chentianping (审核中...)

前往app查看评论内容

#日本#

早期诊断帕金森症有望？日本研发出血液检测法

2019-07-05

chentianping (审核中...)

前往app查看评论内容

#日本#

为何日本中风患者过半康复而中国80%术后不能自理

2019-06-26

chentianping (审核中...)

前往app查看评论内容

#日本#

泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤

2019-06-22

chentianping (审核中...)

前往app查看评论内容

#日本#

日本发现一种抗乙肝病毒化合物

2019-06-22

chentianping (审核中...)

前往app查看评论内容

#日本#

全球首批！第一三共白血病疗法获批日本上市

2019-06-21

科室
- - 订阅+
  - 更多科室
工具
服务